Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2023 Apr 14;69(4):e20220944.
doi: 10.1590/1806-9282.20220944. eCollection 2023.

Transjugular intrahepatic portosystemic shunt in decompensated cirrhotic patients in a tertiary hospital in southern Brazil

Carolina Moro Titton  1 , Marcio Torikachvili  1 , Heloísa M C Rêgo  1 , Eduardo F Medronha  1 , Enio Ziemiecki Junior  1 , Carolina Ribas  1 , Carlos Germano Ceratti  1 , Angelo Alves de Mattos  1 , Cristiane Valle Tovo  1
Affiliations
Observational Study

Transjugular intrahepatic portosystemic shunt in decompensated cirrhotic patients in a tertiary hospital in southern Brazil

Carolina Moro Titton et al. Rev Assoc Med Bras (1992). .

Abstract

Objective: The aim of the present study was to evaluate the outcomes of cirrhotic patients undergoing transjugular intrahepatic portosystemic shunt.

Methods: A retrospective longitudinal observational study was carried out evaluating 38 cirrhotic patients undergoing transjugular intrahepatic portosystemic shunt. The outcomes were evaluated in an outpatient follow-up period of 3 months. The assumed significance level was 5%.

Results: The indications for transjugular intrahepatic portosystemic shunt were refractory ascites in 21 (55.3%), variceal hemorrhage in 13 (34.2%), and hydrothorax in 4 (10.5%) patients. There was development of hepatic encephalopathy in 10 (35.7%) patients after transjugular intrahepatic portosystemic shunt. From the 21 patients with refractory ascites, resolution was observed in 1 (3.1%) patient, and in 16 (50.0%) patients, there was ascites control. Regarding transjugular intrahepatic portosystemic shunt after variceal bleeding, 10 (76.9%) patients remained without new bleeding or hospitalizations in the follow-up period. The global survival in the follow-up period in patients with and without hepatic encephalopathy was 60 vs. 82%, respectively (p=0.032).

Conclusion: Transjugular intrahepatic portosystemic shunt can be considered in decompensated cirrhotic patients; however, the development of hepatic encephalopathy which can shorten survival should be focused.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: the authors declare there is no conflicts of interest.

Figures

Figure 1
Figure 1. Overall survival at 3 months post-transjugular intrahepatic portosystemic shunt according to the presence or absence of hepatic encephalopathy. Kaplan-Meyer curve: p=0.032; hazard ratio=3.04 (95% confidence interval: 1.02–9.08).
Figure 2
Figure 2. Kaplan-Meyer curve to assess the survival of patients with ascites at 3 months post-transjugular intrahepatic portosystemic shunt.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017;65(1):310–335. doi: 10.1002/hep.28906. - DOI - PubMed
    1. Angeli P, Bernardi M, Villanueva C, Francoz C, Mookerjee RP, Trebicka J, et al. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406–460. doi: 10.1016/j.jhep.2018.03.024. - DOI - PubMed
    1. Bittencourt PL, Strauss E, Farias AQ, Mattos AA, Lopes EP. Variceal bleeding: update of recommendations from the Brazilian Association of Hepatology. Arq Gastroenterol. 2017;54(4):349–355. doi: 10.1590/S0004-2803.201700000-79. - DOI - PubMed
    1. Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C; Baveno VII Faculty Baveno VII - renewing consensus in portal hypertension. J Hepatol. 2022;76(4):959–974. doi: 10.1016/j.jhep.2021.12.022. - DOI - PMC - PubMed
    1. Rösch J, Hanafee WN, Snow H. Transjugular portal venography and radiologic portacaval shunt: an experimental study. Radiology. 1969;92(5):1112–1114. doi: 10.1148/92.5.1112. - DOI - PubMed

Publication types

MeSH terms